Cooper Companies | COO - الأصول





الأصول تغيير تاريخ
Abbott USD 110.43B 23.72B 2026-03
Align Technology USD 6.42B 103.41M 2026-06
AtriCure USD 676.64M 32.66M 2026-06
Bausch Health Companies USD 24.79B 296M 2026-06
Baxter International USD 19.79B 55M 2026-06
Bayer EUR 107.29B 659M 2026-06
Becton, Dickinson and Co. USD 50.73B 101M 2026-06
Boston Scientific USD 45.22B 865M 2026-06
Cooper Companies USD 12.48B 58.1M 2026-03
Dentsply International USD 5.2B 25M 2026-06
Dexcom USD 6.46B 178M 2026-06
Edwards Lifesciences USD 13.87B 545.9M 2026-06
Globus Medical USD 5.49B 48.7M 2026-06
Haemonetics USD 2.37B 30.52M 2026-06
Inogen USD 307.01M 5.03M 2025-09
Insulet USD 3.17B 177.9M 2026-06
Integra LifeSciences USD 3.56B 14.24M 2026-06
Intuitive Surgical USD 20.88B 765.6M 2026-06
J&J USD 201.06B 167M 2026-06
Medtronic USD 93.03B 1.54B 2026-03
Merit Medical Systems USD 2.86B 144.34M 2026-06
Novartis USD 118.53B 7.58B 2026-03
ResMed USD 8.97B 181.66M 2026-06
STAAR Surgical USD 475.2M 24.09M 2026-06
Steris USD 10.74B 1.1M 2026-06
Stryker USD 47.93B 1.64B 2026-06
Tandem Diabetes Care USD 1.15B 808K 2026-06
Teleflex USD 6.79B 3.78M 2026-06
Utah Medical Products USD 124.38M 1.84M 2026-03
Zimmer Biomet Holdings USD 22.8B 76.2M 2026-06